Estimates and projections of value of life lost from cancer deaths in the United States
about
Economic burden of occupational injury and illness in the United StatesWhen is cancer care cost-effective? A systematic overview of cost-utility analyses in oncologyEstimating the Population Benefits and Costs of Rituximab Therapy in the United States from 1998 to 2013 Using Real-World DataCost of care for cancer patients in England: evidence from population-based patient-level data.Prognostic significance of grading in lung adenocarcinoma.Berries and ellagic acid prevent estrogen-induced mammary tumorigenesis by modulating enzymes of estrogen metabolism.Cigarette smoking and colorectal cancer risk by molecularly defined subtypes.Dietary freeze-dried black raspberry's effect on cellular antioxidant status during reflux-induced esophagitis in rats.A comparison of cancer burden and research spending reveals discrepancies in the distribution of research funding.Estimating the lifelong health impact and financial burdens of different types of lung cancerAntioxidant, Anti-inflammatory, and Genomic Stability Enhancement Effects of Zinc l-carnosine: A Potential Cancer Chemopreventive Agent?Prevalence of alterations in DNA mismatch repair genes in patients with young-onset colorectal cancer.Productivity savings from colorectal cancer prevention and control strategies.Lung cancer treatment costs, including patient responsibility, by disease stage and treatment modality, 1992 to 2003Economic burden of cancer in the United States: estimates, projections, and future researchFrom cancer screening to treatment: service delivery and referral in the National Breast and Cervical Cancer Early Detection ProgramRegional variations in the economic burden attributable to excess weight, physical inactivity and tobacco smoking across British Columbia.Productivity costs of cancer mortality in the United States: 2000-2020Advancing comparative studies of patterns of care and economic outcomes in cancer: challenges and opportunitiesYears of potential life lost and indirect costs of melanoma and non-melanoma skin cancer: a systematic review of the literature.The cost of premature cancer-related mortality: a review and assessment of the evidence.Temporal trends in healthcare utilization following primary melanoma diagnosis among Medicare beneficiaries.Gold nanorods and curcumin-loaded nanomicelles for efficient in vivo photothermal therapy of Barrett's esophagus.The effect of metastatic site and decade of diagnosis on the individual burden of metastatic melanoma: contemporary estimates of average years of life lost.Economic burden of community-based disease-associated malnutrition in the United States.A finite and stable exponential growth-adjusted indirect cost of cancer associated with discounted years of life lost in Saudi Arabia.Economic Evaluation in Adolescent and Young Adult Cancer: Methodological Considerations and the State of the Science
P2860
Q23914006-386CF900-C679-4367-9EE0-0714581EF30DQ24645229-0D57F8F0-D82E-4D8B-82CA-BFDF68EF0E56Q31036587-84137249-3161-4CA4-AB6B-402243987A77Q31075231-86410289-384A-4161-B462-773B8912C3B7Q33758236-893F79DC-0750-41F7-BF6B-B46FB34BADE7Q33957175-57CD28A4-A0F7-451B-833E-C3B73A5852C1Q34042268-57F7B0EE-415F-481F-83A1-2DE963A7D613Q34130071-2A0D498A-7511-4BEF-8C65-106EBE26AE00Q34338677-13B3416A-7D6D-4B97-93EB-FBDDBAB24E34Q34523410-ABFE1040-AC6B-4E24-A392-71CCAD719A46Q34549429-9292CCA1-EF53-4D45-8FFC-B8A7F21C7680Q34677794-EB8C9C31-288C-4C2D-A906-F707EB28B5B2Q35116457-B197EEA7-44D9-4989-921A-E6F8A0FE8739Q35148957-F741F41C-10B7-4656-B6D8-A3A52556B70AQ35327245-27D2FDD7-F91A-49AD-8506-1E23B5C928D8Q35694177-E4CC6F82-A6BF-4029-8DA4-0462B0C25D29Q37133912-23CCAA80-DB4F-435C-90B5-59AB470DBF58Q37289106-9C10A2EC-704B-4892-B801-0AB9E33D1A61Q37383668-24911C36-9DDB-4A65-944E-3FF7EB59D544Q37918528-58573CC3-8934-4A0D-898D-97CFCBC99DFAQ38205587-E906C2BB-657A-411A-9FD7-7204F269AD2BQ38859865-2F9376EC-38FF-4911-9EA3-AEB9E00211B4Q38906950-84629A73-7169-4AF8-AAD7-D7BBB7ABD10AQ44284985-6481E754-98C0-492A-91AB-6AFF02E1799EQ45950031-3FBFAF46-D5A3-4667-B62C-46097DD2502DQ55252920-0C08C5CB-8B93-4882-9BBB-15480A6F6612Q57896035-0594AE0A-71F5-4ECB-859F-D43456D63E17
P2860
Estimates and projections of value of life lost from cancer deaths in the United States
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Estimates and projections of value of life lost from cancer deaths in the United States
@en
Estimates and projections of value of life lost from cancer deaths in the United States.
@nl
type
label
Estimates and projections of value of life lost from cancer deaths in the United States
@en
Estimates and projections of value of life lost from cancer deaths in the United States.
@nl
prefLabel
Estimates and projections of value of life lost from cancer deaths in the United States
@en
Estimates and projections of value of life lost from cancer deaths in the United States.
@nl
P2093
P2860
P356
P1476
Estimates and projections of value of life lost from cancer deaths in the United States
@en
P2093
Angela B Mariotto
Cathy J Bradley
Eric J Feuer
Martin L Brown
P2860
P304
P356
10.1093/JNCI/DJN383
P407
P50
P577
2008-12-09T00:00:00Z